- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/74 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
Patent holdings for IPC class C07C 235/74
Total number of patents in this class: 164
10-year publication summary
|
14
|
17
|
12
|
6
|
13
|
6
|
6
|
11
|
7
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 453 |
10 |
| Celanese International Corporation | 915 |
7 |
| BASF SE | 21080 |
6 |
| Kthera, LLC | 7 |
5 |
| Bedoukian Research, Inc. | 98 |
4 |
| Givaudan SA | 1901 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 840 |
4 |
| Acuitas Therapeutics Inc. | 119 |
3 |
| Cornell University | 3348 |
3 |
| MedImmune Limited | 625 |
3 |
| Rhodia Operations | 1580 |
3 |
| Saudi Arabian Oil Company | 13569 |
3 |
| The University of British Columbia | 1524 |
3 |
| Bristol-myers Squibb Company | 4848 |
2 |
| LG Chem, Ltd. | 17682 |
2 |
| Ajinomoto Co., Inc. | 2306 |
2 |
| Northwestern University | 3442 |
2 |
| Bio-Pharm Solutions Co., Ltd. | 60 |
2 |
| Daicel Corporation | 2398 |
2 |
| Egis Gyogyszergyar Rt. | 54 |
2 |
| Other owners | 92 |